Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stock Ready To Explode!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

$APLIF stock

Appili Therapeutics Inc. (OTCMKTS:APLIF) (TSX:APLI) Stock Falls 6% In a Week: Company Reports Q3 Earnings

Appili Therapeutics Inc. (OTCMKTS:APLIF) (TSX: APLI) is down 6% in a week. The company has announced its fiscal Q3 2022 financial and operational results for the quarter ending December 31, 2021. Market Stats On Monday, APLIF stock ended flat at $0.0927 with more than 2.3k shares, compared to its average volume of 91K shares. The …

Continue reading “Appili Therapeutics Inc. (OTCMKTS:APLIF) (TSX:APLI) Stock Falls 6% In a Week: Company Reports Q3 Earnings”

Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stocks Ready To Explode!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
*By submitting your information you agree to the terms of our Privacy Policy. You will receive the DRP Journal newsletter, and third party offers. You can unsubscribe anytime by selecting unsubscribe at the bottom of our emails.